Australian pharmacists: ready for increased non-prescription medicines reclassification

Abstract

Objectives Reclassification of medicines from prescription to non-prescription increases timely access to treatment, promotes self-management of minor ailments and relieves healthcare system burden. Previous research identified that Australia lagged behind the United Kingdom and New Zealand in medicines reclassification. This study aimed to identify Australian pharmacists' opinions on the current state of medicines reclassification; the prescription medicines consumers requested without prescription; the medicines pharmacists believed should and should not be considered for reclassification; and perceived barriers to reclassification. Methods A 2016 national online survey that sought pharmacists' opinions on the state of reclassification, perceived barriers to reclassification and readiness of the profession for further reclassification. Pharmacists' comments were invited through open-ended questions. Key findings Two hundred and thirty-five valid surveys were completed. Respondents practised in community, hospital, consultant and academic contexts, and the majority were female (58.7%, n = 138). More than two thirds (70.66%, n = 166) of pharmacists reported receiving daily or weekly requests for non-prescription access to prescription medicines. The majority of pharmacists (71.7%) agreed that the Australian pharmacy profession is ready for further medicines reclassification, guided by patient safety, harm minimisation and medication continuance. The most prominent barrier to further reclassification was opposition from other healthcare professionals.Conclusions Australian pharmacists believe that their profession has the capacity to safely and effectively manage a wider range of non-prescription medicines through increased reclassification in the contexts of patient safety and risk mitigation. This study has contributed to the global conversation on non-prescription medicines access, providing momentum for practice and policy change.

A cross-sectional survey exploring the knowledge, experiences and attitudes of Australian pharmacists toward medicinal cannabis

“…Australian pharmacists have a key role in facilitating access to novel therapeutics and substantial recent experience with medicines being down-scheduled from Prescription Only to Pharmacist Only medicines (e.g., melatonin supply for older people with insomnia, morning-after contraceptives) [ 44 – 46 ]. Pharmacists value their involvement in the discourse around MC, given their essential role in supply [ 1 ].…”

“…Indeed, most pharmacists did not believe they were provided adequate support around cannabis-based medicines and Pharmacist Only CBD products from professional organisations, indicating that a call to action is required in this space. Educational initiatives have accompanied the down-scheduling of other Pharmacist Only products in Australia and resulted in a safe supply of down-scheduled products [ 44 – 46 , 57 ].…”

Barriers and Facilitators for Evidence-Based Self-Care Counselling in Community Pharmacy, a qualitative study

“…Widening access to medicines through reclassi cation ('switching') from prescription to non-prescription is an international trend [33][34][35]. In the Netherlands, OTC medicines consist of three classes: (1) pharmacy only, (2) pharmacy and druggist only, and (3) general sales provided by druggists, supermarkets and other OTC outlets.…”

Antibiotic Misuse Behaviours of Older People: Confirmation of the Factor Structure of the Antibiotic Use Questionnaire

“…An Australian investigation of consumer demand for non-prescription medications by Hope et al (2020) found that 71% of pharmacists were asked by customers for non-prescription access to antibiotics daily or weekly. Up to 75% of pharmacists considered down-scheduling antibiotics to non-prescription status, indicating that increased training in AR-related stewardship policies for pharmacists is required [ 31 ].…”